Nivestym

NDC 0069-0291 · Pfizer Laboratories Div Pfizer Inc

Generic namefilgrastim-aafi

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)FILGRASTIM

Strength300 ug/.5mL

Pharmacologic classGranulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]

Marketing categoryBLA

Packages

0069-0291-01 — 1 SYRINGE in 1 CARTON (0069-0291-01) / .5 mL in 1 SYRINGE

0069-0291-10 — 10 CARTON in 1 CARTON (0069-0291-10) / 1 SYRINGE in 1 CARTON (0069-0291-01) / .5 mL in 1 SYRINGE

Q5110 — Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram Medicare Part B payment limit (ASP + 6%): $0.32

FDA lists these products with the same active ingredient.

0069-0292 — filgrastim-aafi, 0069-0293 — filgrastim-aafi, 0069-0294 — filgrastim-aafi, 55513-209 — Filgrastim, 55513-530 — Filgrastim, 55513-546 — Filgrastim, 55513-924 — Filgrastim, 61314-318 — filgrastim-sndz, 61314-326 — filgrastim-sndz, 63459-910 — tbo-filgrastim, 63459-912 — tbo-filgrastim, 63459-918 — tbo-filgrastim, 63459-920 — tbo-filgrastim, 69097-429 — filgrastim-txid, 69097-430 — filgrastim-txid, 69448-008 — filgrastim-laha, 69448-009 — filgrastim-laha, 70121-1568 — Filgrastim, 70121-1569 — Filgrastim, 70121-1570 — Filgrastim, +3 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.